Bloodloss study after Aortic valve replacement Impact of Mecc perfusion vs conventional ECCperfusio

Completed

• Conditions: Bloodloss; BloodTransfusion; 10064477; 10046973; 10007593

• Registration Number: NL-OMON39590
• Lead Sponsor: Medisch Spectrum Twente

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 310

Inclusion Criteria

Elective indicated AVR procedures

Exclusion Criteria

Redo Hartsurgery

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Lab;C-reactief proteïne, leukocyten, platelets, hemoglobine, hematocriet,<br /><br>creatinine, ureum, glomerular filtration fate**, CK, CKMB, troponine en<br /><br>myoglobine<br /><br>Bloodloss through Thoracicdrains<br /><br>Amount of bloodtransfusion units</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Length of stay on ICU<br /><br>Re-interventions like Re-operatins as a Re-Sternotomia</p><br>